drugset / Trial / NCT02723812
Evaluate Safety of GCFLU® Administered Intramuscularly in Healthy Vietnamese Volunteer Aged From 3 Years Old
Phase 4
Completed
120 enrolled
Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products
Green Cross Corporation · collab
NaSingle-groupOpen-labelPrevention
Summary
An open label, non-comparative bridging study to evaluate the safety of GCFLU® (seasonal influenza vaccine) administered intramuscularly in healthy Vietnamese volunteer aged from 3 years old
Timeline
- Start
- 2015-11
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GCflu | Unknown | 0.5 ml | Intramuscular |